Microalgal omega-3 oils (DHA/EPA) instead of fish oil and krill oil

Replaces: fish and krill oil for EPA/DHA · Scope: supplements, infant formula, premium food · Evidence: high

The chemical problem#

Omega-3 demand runs on wild marine oil: forage-fishery fish oil for supplements and aquaculture feed, plus Antarctic krill oil for the premium shelf. The krill fishery competes with the food web that sustains penguins, seals and whales; forage-fish supplies are capped and El-Nino-sensitive; fish-oil quality varies with oxidation and contaminant scares; and farmed salmon - itself a main omega-3 channel - now carries less EPA/DHA per fillet as feeds reduce fish-oil inclusion. The paradox: the marine food chain makes these fatty acids at the bottom, and the industry catches the middle of the chain to harvest them.

Product overview#

Omega-3 DHA is made by microalgae and thraustochytrids - the same organisms that make it in the ocean, before it concentrates up the food chain. Industrial production ferments them in closed reactors:

1. Heterotrophic fermentation of Schizochytrium: the established workhorse - sugars in, DHA-rich oil out, produced at commercial scale in the EU, US, China and elsewhere; grades for infant formula, supplements and feed.
2. Phototrophic Nannochloropsis and other algae: light-driven EPA production; larger-scale plants being built for feed and food grades.
3. Downstream flexibility: the oil can be formulated for supplements, blended with fish oil for omega-3 balance, added to infant formula, dairy alternatives, and aquafeeds - closing the loop where fish oil demand is largest.

In the catalogue’s rubric map this is the food-ingredient face of a technology that also appears in FD02/FI01: algal oil production serves colour (FI01), protein-plus-DHA feed (FD02), and this article’s pure omega-3 substitution.

Active ingredient / Composition#

Microalgal oil with DHA at 35-55% of total fatty acids (Schizochytrium routes), or EPA-rich oils from Nannochloropsis-type strains; blended omega-3 concentrates balance DHA:EPA ratios. Formulated as triglycerides for food, or re-esterified concentrates for the supplement shelf. No fishy contaminant chain; heavy-metal and PCB profiles are inherently low (controlled fermentation); natural antioxidant stabilisation keeps oxidation in check.

Key facts#

Advantages#

• Decouples omega-3 from wild capture: no krill trawling, no forage-fishery competition; the producing organisms are farmed, not fished.
• Plant-based/vegan suitable: the standard DHA supplement that fits vegetarian, halal and kosher positioning without fish.
• Clean profile: controlled fermentation → no marine contaminant chain, consistent quality lot-to-lot.
• Scalable with demand: capacity follows fermenter investments, not ocean cycles - the answer to aquaculture’s growing omega-3 gap.
• Premium story: brands already market “algal DHA” - the consumer-facing switch is familiar.

Mode of production to application#

• Fermentation (heterotrophic or phototrophic) grows oleaginous microbes that accumulate DHA/EPA-containing triglycerides;
• Cell harvest, oil extraction and refining deliver a clean oil; blending or concentration yields market grades;
• Application: capsules, emulsions and fortified foods; DHA blend into infant formula; oil fraction in salmon and shrimp feeds; dairy and plant-based alternative fortification.

Application#

Limitations#

• Cost premium: algal oil still trades above bulk fish oil; entry is premium, infant and branded segments first - hence Partial on commodity volumes.
• EPA-rich phototrophic routes are commercialising later than DHA-rich fermentation; the full spectrum switch takes a few more years.
• Fermenter capacity build-out needs sugar/glycerol feedstock planning; some routes compete with food markets (side streams improving).
• Claims and fortification rules differ by market; label work per jurisdiction.

Evidence of displacement — D1: works, adoption not proven#

Assessment (hand-reviewed): Only an indirect trade figure (fish-based materials fell from ~75% to ~20% of salmon feed since 1990) — not specific to algal omega-3.

Verified figures (the number is in the quoted sentence and the sentence is on the source page):

• displacement — Fish-based materials in salmon feeds have decreased from approximately 75% in 1990 to approximately 20% currently. (global, 1990-2026; weak: aquafeed.com)
• performance — Algal oil achieves full (100%) fish-oil replacement with no loss in growth or feed conversion ratio in commercial settings. (global, 2025; weak: feedinnovation.org)
• performance — Consultations with industry stakeholders suggest that the average inclusion rate of algae in total aquafeed is currently around 1%, consisting primarily of algae oil. (global, 2025; weak: aquafeed.com)
• performance — Current estimates put the algae-derived EPA and DHA production at around 20,000 metric tonnes in 2025. (global, 2025; weak: aquafeed.com)

Industry pioneers — companies that commercialised this substitution#

Suppliers - real products and services (from the vendor index)#

Companies below are active vendors in the vendor index whose own card (profile / official website) shows this product or service · matched 2026-09-29 by keyword and checked by hand against the card text. Being listed is not an endorsement; open each card for evidence, contacts and status.

Government funding signals#

Scanned 2026-09-29 (OpenAIRE projects + US NSF keyword search); candidates reviewed by hand.

Signal: none located in this scan. No open EU/US/UK grant specifically on microalgal omega-3 surfaced - the field’s funding sits in company programmes (the large producers are private or corporate) and in national aquaculture programmes outside the scan’s vision (Norway, China, Japan). Honest limitation: OpenAIRE + US NSF only.

Scientific evidence#

• Ryckebosch E, Bruneel C, Muylaert K, Foubert I (2012). Microalgae as an alternative source of omega-3 long chain polyunsaturated fatty acids. Lipid Technology 24: 128-130.
• Adarme-Vega TC, Lim DKY, Timmins M, Vernen F, Li Y, Schenk PM (2012). Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microbial Cell Factories 11: 96.
• Doughman SD, Krupanidhi S, Sanjeevi CB (2007). Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Current Diabetes Reviews 3: 198-203.
• Sprague M, Dick JR, Tocher DR (2016). Impact of sustainable feeds on omega-3 long-chain fatty acid levels in farmed Atlantic salmon, 2006-2015. Scientific Reports 6: 21892.
• Tocher DR, Betancor MB, Sprague M, Olsen RE, Napier JA (2019). Omega-3 long-chain polyunsaturated fatty acids, EPA and DHA: bridging the gap between supply and demand. Nutrients 11: 89.

Bioeconomy value#

Microalgal omega-3 completes a neat circle of the bioeconomy: the same microbial biology that makes DHA in the ocean is put in tanks, fed on sugars or light, and returned to the food system as infant formula, supplements and aquafeed - relieving the Antarctic krill and forage-fishery pressure while supplying the fastest-growing omega-3 channel, farmed seafood. It is a substitution measured in tens of thousands of tonnes today and in hundreds of thousands by the 2030s.